Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Stock Market Highlights: 3D Printing Stocks, Analyst Upgrades & More

The US stock market is mixed on Tuesday amid news in the M&A space and Institute for Supply Management’s data that showed non-manufacturing index slump to 51.4, the lowest in six years.

Among the stocks that are trending today are Gilead Sciences, Inc. (NASDAQ:GILD), Goodyear Tire & Rubber Co (NASDAQ:GT), General Electric Company (NYSE:GE), 3D Systems Corporation (NYSE:DDD), and Stratasys, Ltd. (NASDAQ:SSYS). Let’s take a closer look at the latest news surrounding each company and find out what the investors we track at Insider Monkey think about the companies in question.

Hedge fund sentiment is an important metric for assessing the long-term profitability. At Insider Monkey, we track over 700 hedge funds, whose quarterly 13F filings we analyze and determine their collective sentiment towards several thousand stocks. However, our research has shown that the best strategy is to follow hedge funds into their small-cap picks. This approach can allow monthly returns of nearly 95 basis points above the market, as we determined through extensive backtests covering the period between 1999 and 2012 (see the details here).

Great Products to Sell Well Online
Upgrade at Gilead Sciences

Gilead Sciences, Inc. (NASDAQ:GILD)’s shares are 1.4% in the green today after analysts at Jefferies upgraded the stock to ‘Buy’ from ‘Hold’, citing confidence in the company’s HIV treatment prospects. The analysts also think Gilead’s stock already reflects any potential decline in the company’s core HCV franchise and doesn’t give credit to any potential upside pipeline surprises. Like the price action of other big pharma stocks, shares of Gilead have been beaten up in recent weeks due to the Mylan EpiPen controversy and the resulting worries over potential government price regulations for drugs in the future. Jefferies has a $91 price target on Gilead’s stock. Phill Gross and Robert Atchinson‘s Adage Capital Management trimmed its position in Gilead Sciences, Inc. (NASDAQ:GILD) by 5% to slightly over 1.65 million shares during the second quarter.

Follow Gilead Sciences Inc (NASDAQ:GILD)
Trade (NASDAQ:GILD) Now!

Goodyear Gets Thumbs Up

Goodyear Tire & Rubber Co (NASDAQ:GT) is 4% higher after Deutsche Bank upgraded the tire maker to ‘Buy’ from ‘Hold’ and set a $37 price target on the stock. Analysts at the investment bank upgraded the stock because they like Goodyear’s EPS growth potential and its increased capital returns to shareholders. Given the low oil prices, consumers are driving more, and demand for tires should increase, all else equal. A total of 34 funds from our database owned shares of Goodyear Tire & Rubber Co (NASDAQ:GT) at the end of the second quarter, down by two from the previous quarter.

Follow Goodyear Tire & Rubber Co (NASDAQ:GT)
Trade (NASDAQ:GT) Now!

On the next page, we examine why General Electric Company, 3D Systems Corporation, and Stratasys are in the news.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.